Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Proteome Sciences plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proteome Sciences plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proteonomix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proteonomix, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ProtoKinetix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ProtoKinetix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proton Laboratories, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proton Laboratories, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Protox Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Protox Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Provectus Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Provectus Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proximagen Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proximagen Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

pSivida Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

pSivida Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PT Bumi Teknokultura Unggul Tbk Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PT Bumi Teknokultura Unggul Tbk Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pt Indofarma Persero Tbk Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pt Indofarma Persero Tbk Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PT Kalbe Farma Tbk Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PT Kalbe Farma Tbk Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PT Merck Tbk Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PT Merck Tbk Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PT Schering-Plough Indonesia Tbk Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PT Schering-Plough Indonesia Tbk Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pulmo BioTech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pulmo BioTech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Puramed Bioscience Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Puramed Bioscience Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pure Bioscience Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pure Bioscience Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Realm Therapeutics Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Realm Therapeutics Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pyridam Farma tbk PT Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pyridam Farma tbk PT Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Q-Med AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Q-Med AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Qiagen NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Qiagen NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Qianjiang Yongan Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Qianjiang Yongan Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Qingdao Huaren Pharmaceutical Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Qingdao Huaren Pharmaceutical Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Qinghai Gelatin Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Qinghai Gelatin Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

QLT Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

QLT Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

QRxPharma Pty Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

QRxPharma Pty Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Quantum Genomics Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quantum Genomics Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Quest PharmaTech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quest PharmaTech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Questcor Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Questcor Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 72 pages

Quick-Med Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Quick-Med Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

R-Tech Ueno Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

R-Tech Ueno Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Radient Pharmaceuticals Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Radient Pharmaceuticals Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ranaz Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ranaz Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ranbaxy Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ranbaxy Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Raptor Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Raptor Pharmaceuticals Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Re Yon Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Re Yon Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Read-Gene SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Read-Gene SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Recordati SpA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Recordati SpA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Redpoint Bio Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Redpoint Bio Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Reflect Scientific, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reflect Scientific, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ReGen Biologics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ReGen Biologics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ReGen Therapeutics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ReGen Therapeutics plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regeneron Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regeneron Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regenerx Biopharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenerx Biopharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regenicin, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regenicin, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Reliance GeneMedix plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reliance GeneMedix plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ReNeuron Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ReNeuron Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Renhe Pharmacy Co., Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Renhe Pharmacy Co., Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Renovo Group plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Renovo Group plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Repligen Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Repligen Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Repros Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Repros Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1